Creative Financial Designs’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $272K | Buy |
1,954
+202
| +12% | +$28.3K | 0.02% | 453 |
|
|
2025
Q4 | $215K | Buy |
1,752
+386
| +28% | +$46.9K | 0.01% | 459 |
|
|
2025
Q3 | $152K | Sell |
1,366
-56
| -4% | -$6.37K | 0.01% | 538 |
|
|
2025
Q2 | $158K | Buy |
1,422
+86
| +6% | +$9.15K | 0.01% | 551 |
|
|
2025
Q1 | $150K | Buy |
1,336
+28
| +2% | +$2.89K | 0.01% | 517 |
|
|
2024
Q4 | $121K | Sell |
1,308
-1,432
| -52% | -$129K | 0.01% | 557 |
|
|
2024
Q3 | $230K | Buy |
2,740
+189
| +7% | +$14.4K | 0.02% | 417 |
|
|
2024
Q2 | $175K | Buy |
2,551
+1,320
| +107% | +$88.1K | 0.02% | 461 |
|
|
2024
Q1 | $90.1K | Sell |
1,231
-208
| -14% | -$16K | 0.01% | 588 |
|
|
2023
Q4 | $117K | Buy |
1,439
+234
| +19% | +$18.2K | 0.01% | 510 |
|
|
2023
Q3 | $90.3K | Buy |
1,205
+3
| +0.2% | +$231 | 0.01% | 507 |
|
|
2023
Q2 | $92.6K | Buy |
1,202
+3
| +0.3% | +$239 | 0.01% | 506 |
|
|
2023
Q1 | $99.5K | Sell |
1,199
-115
| -9% | -$9.53K | 0.01% | 462 |
|
|
2022
Q4 | $113K | Sell |
1,314
-72
| -5% | -$5.7K | 0.02% | 429 |
|
|
2022
Q3 | $86K | Buy |
1,386
+100
| +8% | +$6.31K | 0.01% | 464 |
|
|
2022
Q2 | $79K | Sell |
1,286
-3
| -0.2% | -$186 | 0.01% | 472 |
|
|
2022
Q1 | $77K | Buy |
1,289
+119
| +10% | +$7.61K | 0.01% | 473 |
|
|
2021
Q4 | $85K | Sell |
1,170
-1,383
| -54% | -$95.3K | 0.01% | 466 |
|
|
2021
Q3 | $178K | Buy |
2,553
+103
| +4% | +$7.24K | 0.03% | 318 |
|
|
2021
Q2 | $169K | Buy |
2,450
+128
| +6% | +$8.55K | 0.03% | 324 |
|
|
2021
Q1 | $150K | Buy |
2,322
+41
| +2% | +$2.64K | 0.03% | 328 |
|
|
2020
Q4 | $133K | Buy |
2,281
+492
| +28% | +$29.7K | 0.03% | 324 |
|
|
2020
Q3 | $113K | Buy |
1,789
+536
| +43% | +$37.2K | 0.03% | 321 |
|
|
2020
Q2 | $96K | Buy |
+1,253
| New | +$96K | 0.03% | 296 |
|
|
2020
Q1 | – | Sell |
-226
| Closed | -$15.6K | – | 516 |
|
|
2019
Q4 | $15K | Sell |
226
-181
| -44% | -$11.8K | 0.01% | 353 |
|
|
2019
Q3 | $25K | Buy |
407
+11
| +3% | +$719 | 0.01% | 309 |
|
|
2019
Q2 | $27K | Sell |
396
-64
| -14% | -$4.21K | 0.01% | 286 |
|
|
2019
Q1 | $30K | Buy |
460
+165
| +56% | +$11K | 0.02% | 261 |
|
|
2018
Q4 | $18K | Sell |
295
-344
| -54% | -$24K | 0.01% | 289 |
|
|
2018
Q3 | $49K | Sell |
639
-373
| -37% | -$28.2K | 0.03% | 230 |
|
|
2018
Q2 | $72K | Buy |
1,012
+148
| +17% | +$10.5K | 0.04% | 202 |
|
|
2018
Q1 | $65K | Buy |
864
+204
| +31% | +$16.2K | 0.04% | 197 |
|
|
2017
Q4 | $47K | Buy |
660
+228
| +53% | +$17.3K | 0.03% | 224 |
|
|
2017
Q3 | $35K | Sell |
432
-3,415
| -89% | -$261K | 0.02% | 270 |
|
|
2017
Q2 | $272K | Sell |
3,847
-969
| -20% | -$64.5K | 0.17% | 113 |
|
|
2017
Q1 | $327K | Buy |
4,816
+632
| +15% | +$44.4K | 0.24% | 101 |
|
|
2016
Q4 | $300K | Buy |
+4,184
| New | +$311K | 0.24% | 89 |
|
Other funds holding GILD
VCM
VPM
Creative Financial Designs's GILD Position: Q1 2026 in Review
Creative Financial Designs increased its Gilead Sciences (GILD) stake by 12% in Q1 2026, buying an estimated $28.3K and bringing the position to 1,954 shares worth $272K. The position accounts for 0.02% of the portfolio, ranked #453.
Creative Financial Designs first reported a position in GILD in Q4 2016 and has held it in 37 quarters since. The position peaked at $327K in Q1 2017. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- Creative Financial Designs held 1,954 shares of Gilead Sciences worth $272K as of Q1 2026.
- Creative Financial Designs bought 202 Gilead Sciences shares in Q1 2026, an estimated $28.3K.
- Gilead Sciences made up 0.02% of Creative Financial Designs's portfolio in Q1 2026, its #453 holding.
- Creative Financial Designs first reported a position in Gilead Sciences in Q4 2016 and has held it in 37 quarters since.
- Creative Financial Designs's Gilead Sciences position peaked at $327K in Q1 2017.
- 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on Creative Financial Designs's 13F filing for Q1 2026, filed 13 Apr 2026.